So, we demonstrated the significance of E2Fs in GC from different perspectives and suggested that E2F1/2/3/5/8 could serve as potential biomarkers for GC patients with high prognostic value for OS of GC patients or therapeutic targets for GC. The gene discussed is E2F1; the disease is gastric cancer.